Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04619316
Title Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition (ERRITI)
Acronym ERRITI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital, Essen
Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST